HB2133 POLPCS1 Steve Bashore-TJ
2/11/2025 3:24:35 pm
COMMITTEE AMENDMENT
HOUSE OF REPRESENTATIVES
State of Oklahoma
SPEAKER:
CHAIR:
I move to amend HB2133
Of the printed Bill
Page Section Lines
Of the Engrossed Bill
By deleting the content of the entire measure, and by inserting in lieu
thereof the following language:
ste
AMEND TITLE TO CONFORM TO AMENDMENTS
Amendment submitted by: Steve Bashore
Adopted: _____________________________
______________________________________
Reading Clerk

1 STATE OF OKLAHOMA
2 1st Session of the 60th Legislature (2025)
3 PROPOSED POLICY
COMMITTEE SUBSTITUTE
4 FOR
HOUSE BILL NO. 2133 By: Bashore
5
6
7
8 PROPOSED POLICY COMMITTEE SUBSTITUTE
9 An Act relating to out-of-state prescribers; amending
59 O.S. 2021, Section 353.1a, which relates to
10 prescribing authority for Advanced Practice
Registered Nurses; allowing pharmacists to dispense
11 noncontrolled and controlled prescriptions from out-
of-state prescribers; providing for certain
12 requirements; amending 63 O.S. 2021, Section 2-302,
as last amended by Section 1, Chapter 328, O.S.L.
13 2024 (63 O.S. Supp. 2024, Section 2-302), which
relates to registration requirements; allowing out-
14 of-state prescribers to be exempt from registering
with the Oklahoma State Bureau of Narcotics and
15 Dangerous Drugs Control; and providing an effective
date.
16
17
18 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
19 SECTION 1. AMENDATORY 59 O.S. 2021, Section 353.1a, is
20 amended to read as follows:
21 Section 353.1a. A. Prescribing authority shall be allowed,
22 under the medical direction of a supervising physician, for an
23 advanced practice nurse recognized by the Oklahoma Board of Nursing
24 in one of the following categories: advanced registered nurse
Req. No. 12463 Page 1

1 prac titioners, clinical nurse specialists, or certified nurse-
2 midwives. The advanced practice nurse may write or sign, or
3 transmit by word of mouth, telephone or other means of communication
4 an order for drugs or medical supplies that is intended to be
5 filled, compounded, or dispensed by a pharmacist. The supervising
6 physician and the advanced practice nurse shall be identified at the
7 time of origination of the prescription and the name of the advanced
8 practice nurse shall be printed on the prescription label.
9 B. Pharmacists may dispense prescriptions for noncontrolled
10 prescription drugs authorized by an out-of-state licensed
11 practitioner, as defined in Section 353.1 of this title, if the
12 licensed practitioner is lawfully licensed and in good standing in
13 the state in which he or she is actively prescribing and if the
14 noncontrolled prescription is otherwise lawful under Oklahoma law.
15 Pharmacists may dispense prescriptions for non-controlled
16 noncontrolled prescription drugs authorized by an advanced practice
17 nurse or physician assistant, not located in Oklahoma, provided that
18 they are he or she is licensed in the state in which they are he or
19 she is actively prescribing.
20 C. Pharmacists may dispense prescriptions for controlled
21 dangerous substances prescribed by an out-of-state licensed
22 practitioner, as defined in Section 353.1 of this title, if the
23 licensed practitioner is lawfully licensed and in good standing in
24 the state in which he or she is actively prescribing and if the
Req. No. 12463 Page 2

1 cont rolled dangerous substance is otherwise lawful under Oklahoma
2 law. Pharmacists may only dispense prescriptions for controlled
3 dangerous substances prescribed by an advanced practice nurse or
4 physician assistant licensed in the State of Oklahoma and supervised
5 by an Oklahoma-licensed practitioner, provided the controlled
6 dangerous substance is otherwise lawful under Oklahoma Law.
7 SECTION 2. AMENDATORY 63 O.S. 2021, Section 2-302, as
8 last amended by Section 1, Chapter 328, O.S.L. 2024 (63 O.S. Supp.
9 2024, Section 2-302), is amended to read as follows:
10 Section 2-302. A. Every Except as otherwise provided by law,
11 every person who manufactures, distributes, dispenses, prescribes,
12 administers or uses for scientific purposes any controlled dangerous
13 substance within or into this state, or who proposes to engage in
14 the manufacture, distribution, dispensing, prescribing,
15 administering or use for scientific purposes of any controlled
16 dangerous substance within or into this state shall obtain a
17 registration issued by the Director of the Oklahoma State Bureau of
18 Narcotics and Dangerous Drugs Control, in accordance with rules
19 promulgated by the Director. Persons registered by the Director
20 under Section 2-101 et seq. of this title to manufacture,
21 distribute, dispense or conduct research with controlled dangerous
22 substances may possess, manufacture, distribute, dispense or conduct
23 research with those substances to the extent authorized by their
24 registration and in conformity with the other provisions of the
Req. No. 12463 Page 3

1 Unif orm Controlled Dangerous Substances Act. Every wholesaler,
2 manufacturer or distributor of any drug product containing
3 pseudoephedrine or phenylpropanolamine, or their salts, isomers or
4 salts of isomers, shall obtain a registration issued by the Director
5 of the Oklahoma State Bureau of Narcotics and Dangerous Drugs
6 Control in accordance with rules promulgated by the Director and as
7 provided for in Section 2-332 of this title. Any person who
8 manufactures, distributes, dispenses, prescribes, administers or
9 uses for scientific purposes any controlled dangerous substances
10 within or into this state without first obtaining a registration
11 issued by the Director of the Oklahoma State Bureau of Narcotics and
12 Dangerous Drugs Control shall be subject to the same statutory and
13 administrative jurisdiction of the Director as if that person were
14 an applicant or registrant.
15 B. Out-of-state pharmaceutical suppliers who provide controlled
16 dangerous substances to individuals within this state shall obtain a
17 registration issued by the Director of the Oklahoma State Bureau of
18 Narcotics and Dangerous Drugs Control, in accordance with rules
19 promulgated by the Director. This provision shall also apply to
20 wholesale distributors who distribute controlled dangerous
21 substances to pharmacies or other entities registered within this
22 state in accordance with rules promulgated by the Director.
23 C. Every person who owns in whole or in part a public or
24 private medical facility for which a majority of patients are issued
Req. No. 12463 Page 4

1 on a reoccurring monthly basis a prescription for opioids,
2 benzodiazepines, barbiturates or carisoprodol, but not including
3 buprenorphine with naloxone or buprenorphine as used for medication-
4 assisted treatment services, shall obtain a registration issued by
5 the Director of the Oklahoma State Bureau of Narcotics and Dangerous
6 Drugs Control.
7 D. Every manufacturer and distributor required to register
8 under the provisions of this section shall provide all data required
9 pursuant to 21 U.S.C., Section 827(d)(1) on a monthly basis to the
10 Oklahoma State Bureau of Narcotics and Dangerous Drugs Control.
11 Controlled dangerous substances in Schedule I shall be reported in
12 accordance with rules promulgated by the Director. Reporting of
13 controlled dangerous substances pursuant to 21 U.S.C., Section
14 827(d)(1) shall include, but not be limited to:
15 1. The manufacturer's or distributor's name, address, phone
16 number, DEA registration number and controlled dangerous substance
17 registration number issued by the Bureau;
18 2. The name, address and DEA registration number of the entity
19 to whom the controlled dangerous substance was sold;
20 3. The date of the sale of the controlled dangerous substance;
21 4. The name and National Drug Code of the controlled dangerous
22 substance sold; and
23 5. The number of containers and the strength and quantity of
24 controlled dangerous substances in each container sold.
Req. No. 12463 Page 5

1 E. The information maintained and provided pursuant to
2 subsection D of this section shall be confidential and not open to
3 the public. Access to the information shall, at the discretion of
4 the Director, be limited to:
5 1. Peace officers certified pursuant to the provisions of
6 Section 3311 of Title 70 of the Oklahoma Statutes who are employed
7 as investigative agents of the Oklahoma State Bureau of Narcotics
8 and Dangerous Drugs Control or the Office of the Attorney General;
9 2. The United States Drug Enforcement Administration Diversion
10 Group Supervisor; and
11 3. A multicounty grand jury properly convened pursuant to the
12 provisions of the Multicounty Grand Jury Act.
13 F. Manufacturers, distributors, home care agencies, hospices,
14 home care services, medical facility owners referred to in
15 subsection C of this section and scientific researchers shall obtain
16 a registration annually. Other practitioners shall obtain a
17 registration for a period to be determined by the Director that will
18 be for a period not less than one (1) year nor more than three (3)
19 years.
20 G. Every trainer or handler of a canine controlled dangerous
21 substances detector who, in the ordinary course of such trainer's or
22 handler's profession, desires to possess any controlled dangerous
23 substance, annually, shall obtain a registration issued by the
24 Director for a fee of Seventy Dollars ($70.00). Such persons shall
Req. No. 12463 Page 6

1 be s ubject to all applicable provisions of Section 2-101 et seq. of
2 this title and such applicable rules promulgated by the Director for
3 those individuals identified in subparagraph a of paragraph 32 42 of
4 Section 2-101 of this title. Persons registered by the Director
5 pursuant to this subsection may possess controlled dangerous
6 substances to the extent authorized by their registration and in
7 conformity with the other provisions of the Uniform Controlled
8 Dangerous Substances Act.
9 H. The following persons shall not be required to register and
10 may lawfully possess controlled dangerous substances under the
11 provisions of Section 2-101 et seq. of this title:
12 1. An agent, or an employee thereof, of any registered
13 manufacturer, distributor, dispenser or user for scientific purposes
14 of any controlled dangerous substance, if such agent is acting in
15 the usual course of such agent's or employee's business or
16 employment;
17 2. Any person lawfully acting under the direction of a person
18 authorized to administer controlled dangerous substances under
19 Section 2-312 of this title;
20 3. A common or contract carrier or warehouser, or an employee
21 thereof, whose possession of any controlled dangerous substance is
22 in the usual course of such carrier's or warehouser's business or
23 employment;
24
Req. No. 12463 Page 7

1 4. An ultimate user or a person in possession of any controlled
2 dangerous substance pursuant to a lawful order of a practitioner;
3 5. An individual pharmacist acting in the usual course of such
4 pharmacist's employment with a pharmacy registered pursuant to the
5 provisions of Section 2-101 et seq. of this title;
6 6. A nursing home licensed by this state;
7 7. Any Department of Mental Health and Substance Abuse Services
8 employee or any person whose facility contracts with the Department
9 of Mental Health and Substance Abuse Services whose possession of
10 any dangerous drug, as defined in Section 353.1 of Title 59 of the
11 Oklahoma Statutes, is for the purpose of delivery of a mental health
12 consumer's medicine to the consumer's home or residence;
13 8. Registered nurses and licensed practical nurses; and
14 9. An assisted living facility licensed by this state; and
15 10. An out-of-state licensed practitioner, as defined in
16 Section 353.1 of Title 59 of the Oklahoma Statutes, if the licensed
17 practitioner is lawfully licensed and in good standing in the state
18 in which he or she is actively prescribing prescription or
19 nonprescription drugs, including controlled substances, that are
20 lawful under Oklahoma law.
21 I. The Director may, by rule, waive the requirement for
22 registration or fee for registration of certain manufacturers,
23 distributors, dispensers, prescribers, administrators or users for
24
Req. No. 12463 Page 8

1 scie ntific purposes if the Director finds it consistent with the
2 public health and safety.
3 J. A separate registration shall be required at each principal
4 place of business or professional practice where the applicant
5 manufactures, distributes, dispenses, prescribes, administers or
6 uses for scientific purposes controlled dangerous substances.
7 K. The Director is authorized to inspect the establishment of a
8 registrant or applicant for registration in accordance with rules
9 promulgated by the Director.
10 L. No person engaged in a profession or occupation for which a
11 license to engage in such activity is provided by law shall be
12 registered under the Uniform Controlled Dangerous Substances Act
13 unless such person holds a valid license of such person's profession
14 or occupation.
15 M. Registrations shall be issued on the first day of November
16 of each year and shall expire annually. Registrations may be issued
17 at other times, however, upon certification of the professional
18 licensing board. Registration applications shall be required
19 annually thereafter.
20 N. The licensing boards of all professions and occupations to
21 which the use of controlled dangerous substances is incidental shall
22 furnish a current list to the Director, not later than the first day
23 of October of each year, of the persons holding valid licenses. All
24 such persons except persons exempt from registration requirements
Req. No. 12463 Page 9

1 unde r subsection H of this section shall be subject to the
2 registration requirements of Section 2-101 et seq. of this title.
3 O. The licensing board of any professional defined as a mid-
4 level practitioner shall notify and furnish to the Director, not
5 later than the first day of October of each year, that such
6 professional holds a valid license, a current listing of individuals
7 licensed and registered with their respective boards to prescribe,
8 order, select, obtain and administer controlled dangerous
9 substances. The licensing board shall immediately notify the
10 Director of any action subsequently taken against any such
11 individual.
12 P. Beginning November 1, 2010, each registrant that prescribes,
13 administers or dispenses methadone shall be required to check the
14 prescription profile of the patient on the central repository of the
15 Oklahoma State Bureau of Narcotics and Dangerous Drugs Control.
16 Q. All legal entities applying for or approved for registration
17 shall disclose to the Director all beneficial owners of the legal
18 entity. Publicly traded entities shall be exempt from full
19 disclosure; provided that, the publicly traded entity discloses to
20 the Director all beneficial owners who exercise authority or control
21 over controlled dangerous substances at each registered location.
22 R. No registration, or any authority conferred thereby, shall
23 be leased, assigned, or otherwise transferred. No registration
24 shall be transferrable on change of ownership or business activity.
Req. No. 12463 Page 10

1 SECTION 3. This act shall become effective November 1, 2025.
2
3 60-1-12463 TJ 02/10/25
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Req. No. 12463 Page 11

[DELETED: 2 AS C           O S L           ]
[DELETED:  P B]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P T 0]